Case Commentary: Successful use of olorofim for the treatment of multi-drug-resistant <i>Lomentospora prolificans</i> infection in a child
<i>Lomentospora prolificans</i> is a multi-drug-resistant filamentous fungus that can cause invasive disease in both immunocompromised and immunocompetent hosts. Current treatment options are limited. Olorofim is an investigational antifungal that demonstrates activity against several different molds, including many that are resistant to other antifungals. The case presented by Fortini et al. (Antimicrob Agents Chemother 69:e00602-25, 2025, https://doi.org/10.1128/aac.00602-25) describes the successful use of olorofim treatment in an 8-year-old who suffered from <i>Lomentospora prolificans</i> tendonitis, synovitis, and osteomyelitis.
Authors
- Nathan P. Wiederhold (ORCID: https://orcid.org/0000-0002-2225-5122)
Institutions
- The University of Texas at San Antonio Health Science Center (US)
- The University of Texas at San Antonio (US)
Publication Details
- Journal
- Antimicrobial Agents and Chemotherapy
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1128/aac.01072-25
- Citations
- 1
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 1.40